BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 36763330)

  • 1. Control of the post-infarct immune microenvironment through biotherapeutic and biomaterial-based approaches.
    Soni SS; D'Elia AM; Rodell CB
    Drug Deliv Transl Res; 2023 Jul; 13(7):1983-2014. PubMed ID: 36763330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Biomaterials in Cardiac Repair and Regeneration: Therapeutic Intervention for Myocardial Infarction.
    Tariq U; Gupta M; Pathak S; Patil R; Dohare A; Misra SK
    ACS Biomater Sci Eng; 2022 Aug; 8(8):3271-3298. PubMed ID: 35867701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac tissue engineering for myocardial infarction treatment.
    Gil-Cabrerizo P; Scacchetti I; Garbayo E; Blanco-Prieto MJ
    Eur J Pharm Sci; 2023 Jun; 185():106439. PubMed ID: 37003408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of biomedical materials in the diagnosis and treatment of myocardial infarction.
    Zhang J; Guo Y; Bai Y; Wei Y
    J Nanobiotechnology; 2023 Aug; 21(1):298. PubMed ID: 37626396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomaterials for the treatment of myocardial infarction.
    Christman KL; Lee RJ
    J Am Coll Cardiol; 2006 Sep; 48(5):907-13. PubMed ID: 16949479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of immune cell-derived exosomes in the cardiac tissue repair after myocardial infarction: Molecular mechanisms and pre-clinical evidence.
    Wen H; Peng L; Chen Y
    J Cell Mol Med; 2021 Jul; 25(14):6500-6510. PubMed ID: 34092017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomaterial strategies for alleviation of myocardial infarction.
    Venugopal JR; Prabhakaran MP; Mukherjee S; Ravichandran R; Dan K; Ramakrishna S
    J R Soc Interface; 2012 Jan; 9(66):1-19. PubMed ID: 21900319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Material-based engineering strategies for cardiac regeneration.
    Marion MH; Bax NA; Spreeuwel AC; van der Schaft DW; Bouten CV
    Curr Pharm Des; 2014; 20(12):2057-68. PubMed ID: 23886381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regenerative approaches to post-myocardial infarction heart failure.
    Martin K; Huang CL; Caplice NM
    Curr Pharm Des; 2014; 20(12):1930-40. PubMed ID: 23844736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bioresorbable biomaterial carrier and passive stabilization device to improve heart function post-myocardial infarction.
    Dolan EB; Hofmann B; de Vaal MH; Bellavia G; Straino S; Kovarova L; Pravda M; Velebny V; Daro D; Braun N; Monahan DS; Levey RE; O'Neill H; Hinderer S; Greensmith R; Monaghan MG; Schenke-Layland K; Dockery P; Murphy BP; Kelly HM; Wildhirt S; Duffy GP
    Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109751. PubMed ID: 31349422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epicardial infarct repair with basic fibroblast growth factor-enhanced CorMatrix-ECM biomaterial attenuates postischemic cardiac remodeling.
    Mewhort HE; Turnbull JD; Meijndert HC; Ngu JM; Fedak PW
    J Thorac Cardiovasc Surg; 2014 May; 147(5):1650-9. PubMed ID: 24075463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial: Novel strategies for cardiac repair post-myocardial infarction.
    Agathopoulos S; Kolettis TM
    Curr Pharm Des; 2014; 20(12):1925-9. PubMed ID: 23844729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomaterials for the treatment of myocardial infarction: a 5-year update.
    Rane AA; Christman KL
    J Am Coll Cardiol; 2011 Dec; 58(25):2615-29. PubMed ID: 22152947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial tissue engineering: a review.
    Jawad H; Ali NN; Lyon AR; Chen QZ; Harding SE; Boccaccini AR
    J Tissue Eng Regen Med; 2007; 1(5):327-42. PubMed ID: 18038427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for Mechanisms Underlying the Functional Benefits of a Myocardial Matrix Hydrogel for Post-MI Treatment.
    Wassenaar JW; Gaetani R; Garcia JJ; Braden RL; Luo CG; Huang D; DeMaria AN; Omens JH; Christman KL
    J Am Coll Cardiol; 2016 Mar; 67(9):1074-1086. PubMed ID: 26940929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infarct restraint to limit adverse ventricular remodeling.
    Gorman RC; Jackson BM; Burdick JA; Gorman JH
    J Cardiovasc Transl Res; 2011 Feb; 4(1):73-81. PubMed ID: 21161462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cell delivery strategies to promote cardiac regeneration following ischemic injury.
    Russo V; Young S; Hamilton A; Amsden BG; Flynn LE
    Biomaterials; 2014 Apr; 35(13):3956-74. PubMed ID: 24560461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue engineering for post-myocardial infarction ventricular remodeling.
    Kolettis TM; Vilaeti A; Dimos K; Tsitou N; Agathopoulos S
    Mini Rev Med Chem; 2011 Mar; 11(3):263-70. PubMed ID: 21222573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for recruitment of stem cells to treat myocardial infarction.
    Shafiq M; Lee SH; Jung Y; Kim SH
    Curr Pharm Des; 2015; 21(12):1584-97. PubMed ID: 25594408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.